ReCode Therapeutics Competitors and Similar CompaniesClear all
ReCode Therapeutics's competitors and similar companies include BillionToOne and PTC Therapeutics.
 ReCode Therapeutics ReCode Therapeutics is a company developing non-viral nanoparticles for delivery of diverse RNA- and protein-based therapeutics to targeted tissues, and tRNA NanoCorrectors. |  BillionToOne BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options. |  PTC Therapeutics PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs. | |
Founding Date | Founding Date 2015 | Founding Date 2016 | Founding Date 1998 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Menlo Park, US HQ | Locations South Plainfield, US HQ |
Employees | Employees 1062% decrease | Employees 620 | Employees 75448% increase |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $305.1m (FY, 2025) | Revenue (est.) $1.7b (FY, 2025) |
Net income | Net income N/A | Net income $7.5m (FY, 2025) | Net income $682.6m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 82m | Total funding raised $ 87.5m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BillionToOne
HQ
Menlo Park, US
Employees
620
BillionToOne is a precision diagnostics company offering prenatal cystic fibrosis and spinal muscular atrophy screening options.
View companyPTC Therapeutics
HQ
South Plainfield, US
Employees
754↑ 48% increase
PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development, and commercialization of small-molecule drugs.
View company